These results suggest that the MAPK/ERK1/2 pathway is required for GPR48/LGR48-mediated β-catenin signaling, and that post-transcriptional regulation of GPR48/LGR4 in differentiated thyroid carcinoma may be influenced by inhibition of RAF and MEK. Here, MAP2K7 is linked to thyroid gland carcinoma.